Use of Palliative Care in Managing Genitourinary Malignancies May Vary Across the United States
Patients with GU malignancies were more likely to receive palliative care if they were in the West compared with other US regions.
Diagnosis & Disease Information
Pembrolizumab Shows Promise for BCG-Unresponsive Bladder Cancer
Pembrolizumab, a PD-1 inhibitor, demonstrated antitumor activity in patients with high-risk BCG-unresponsive carcinoma in situ.
‘Fake’ Drug Distribution Growing, FDA Warns
Health care providers ordering meds should view ‘too good to be true’ offers with suspicion, agency says.
- Loading...
Loading...
Next post in News
Loading... 
Loading...